Michael Goode

Cytocore: More Management by Hype and Distortion

The correction mentioned in my above comment has been made to the article now.

Cytocore: More Management by Hype and Distortion

Also, please note the following correction: the $1.5 million is not the cash burn but the negative cash flow from operations; the company's cash did not decline over the last year, but only because it issued shares and certain investors exercised warrants. So while the company is not closer to bankruptcy than it was a year ago, it is financially weak and it will need to continue to issue shares to survive. I still believe that management's buying of shares is not nearly as positive an event as the press release made it seem.

A corrected version appears on my blog. I apologize for any errors.
www.goodevalue.com/200.../

Cytocore: More Management by Hype and Distortion

Hey, I hope you are right and the product is good and the company can capitalize on it. If so, the world will be a better place. I will certainly not be investing, though.